11:05 AM EDT, 03/26/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were modestly lower late Wednesday morning, declining 0.31% to 1,424.06 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by furniture manufacturer Natuzzi (NTZ) and biotech firm Evaxion Biotech ( EVAX ) , which rose 6.1% and 4.5% respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and oil and gas company TotalEnergies (TTE), which were up 3.5% and 2.8% respectively.

The decliners from continental Europe were led by software firm SAP (SAP) and medical device maker EDAP TMS ( EDAP ) , which fell 2.7% and 1.4% respectively. They were followed by biopharmaceutical company argenx (ARGX) and internet browser company Opera (OPRA), which lost 2.5% and 1% respectively.

From the UK and Ireland, the gainers were led by oil and gas company Shell (SHEL) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which increased 1.9% and 0.3% respectively. They were followed by oil and gas company BP (BP) and medical device maker Smith & Nephew ( SNN ) , which rose 1% and 0.8% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Mereo BioPharma Group ( MREO ) , which dropped 5.8% and 3.2% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company NuCana ( NCNA ) , which were down 2.7% and 1.9% respectively.